Twinbeech Capital LP Invests $2.51 Million in Chemed Co. (NYSE:CHE)

Twinbeech Capital LP purchased a new position in shares of Chemed Co. (NYSE:CHE - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 4,730 shares of the company's stock, valued at approximately $2,506,000.

A number of other hedge funds and other institutional investors have also modified their holdings of CHE. UMB Bank n.a. increased its position in Chemed by 300.0% during the fourth quarter. UMB Bank n.a. now owns 52 shares of the company's stock worth $28,000 after buying an additional 39 shares during the last quarter. Atala Financial Inc acquired a new position in shares of Chemed during the 4th quarter valued at about $29,000. CBIZ Investment Advisory Services LLC raised its stake in shares of Chemed by 64.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after acquiring an additional 22 shares in the last quarter. Trust Co. of Vermont acquired a new stake in Chemed in the 4th quarter worth approximately $34,000. Finally, Tortoise Investment Management LLC lifted its holdings in Chemed by 77.3% in the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock worth $41,000 after purchasing an additional 34 shares during the last quarter. Institutional investors own 95.85% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have commented on CHE shares. Royal Bank of Canada increased their price target on Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a report on Monday, April 28th. Wall Street Zen upgraded shares of Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th.

Chemed Price Performance

CHE stock traded up $7.54 on Monday, reaching $568.98. 113,071 shares of the company were exchanged, compared to its average volume of 103,064. The firm has a market capitalization of $8.32 billion, a PE ratio of 28.75, a PEG ratio of 2.15 and a beta of 0.59. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $623.61. The stock's fifty day moving average price is $583.60 and its 200 day moving average price is $565.52.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.59 by $0.04. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company had revenue of $646.94 million for the quarter, compared to the consensus estimate of $641.78 million. During the same quarter in the previous year, the firm posted $5.20 EPS. The business's revenue was up 9.8% compared to the same quarter last year. As a group, research analysts expect that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Shareholders of record on Thursday, May 29th will be given a $0.50 dividend. The ex-dividend date of this dividend is Thursday, May 29th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. Chemed's dividend payout ratio is currently 9.74%.

Insider Transactions at Chemed

In related news, EVP Spencer S. Lee sold 1,500 shares of the business's stock in a transaction on Friday, May 16th. The stock was sold at an average price of $577.99, for a total value of $866,985.00. Following the sale, the executive vice president now owns 14,627 shares of the company's stock, valued at $8,454,259.73. The trade was a 9.30% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Kevin J. Mcnamara sold 1,000 shares of the company's stock in a transaction on Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the sale, the chief executive officer now owns 101,679 shares in the company, valued at $62,566,139.07. This trade represents a 0.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 7,500 shares of company stock valued at $4,401,120. 3.29% of the stock is owned by corporate insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.